Welcome to PsychU!

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses his co-authored publication “Long-Acting Injectable Antipsychotics For Schizophrenia: Sociodemographic Characteristics & Treatment Adherence,” which published February 2017 in Primary Care Companion For CNS Disorders. Dr. McCreath shares his insights and perspectives on long-acting injectable antipsychotics (LAIs) in mental health, with Joe Cirrincione, PharmD, MBA, and Becky Wong, PharmD, MBA, members of the Otsuka Pharmaceutical Development & Commercialization, Inc. Field Medical …

Join PsychU today at no cost for access to this and other premium content!

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Name*
Specialty (select all that apply)*
Zip / Postal Code*

Choose Your Unique Login

Your username can only contain lowercase letters (a-z) and numbers.
Email*
Password*
Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

I agree to the following terms

I agree to the following terms:*
I agree to the following terms*
Hidden
Direct Care Provider
Hidden
Clinician Newsletter
Hidden
Management Newsletter
Hidden
user_preferences_account_notifications
Hidden
user_preferences_webinar_emails
This field is for validation purposes and should be left unchanged.